BDBM63213 MLS000584872::N-(2,4-dimethylphenyl)-2-(4-pyrrol-1-ylphenyl)acetamide::N-(2,4-dimethylphenyl)-2-(4-pyrrol-1-ylphenyl)ethanamide::N-(2,4-dimethylphenyl)-2-[4-(1-pyrrolyl)phenyl]acetamide::N-(2,4-dimethylphenyl)-2-[4-(1H-pyrrol-1-yl)phenyl]acetamide::SMR000207257::cid_3310271

SMILES Cc1cccc(-c2nn(CC(=O)Nc3cc(F)cc(C(=O)O[C@H]4CN5CCC4CC5)c3)cc2-c2ccnc3ccccc23)n1

InChI Key InChIKey=MFZSULJTWNSMCV-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 63213   

TargetTGF-beta receptor type-1(Human)
Agomab Spain S.L.U.

US Patent
LigandChemical structure of BindingDB Monomer ID 63213BDBM63213((S)-quinuclidin-3-yl 3-fluoro-5-(2-(3-(6-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent